diaDexus, Inc. – ‘8-K’ for 7/2/02

On:  Monday, 7/15/02, at 4:35pm ET   ·   For:  7/2/02   ·   Accession #:  1169232-2-143   ·   File #:  0-26483

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     12K 
 2: EX-99.1     Press Release Issued July 2, 2002                      2     10K 
 3: EX-99.2     Amended and Restated License and Supply Agreement     31    120K 
 4: EX-99.3     Press Release Issued July 8, 2002                      2     11K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 -------------------------

FORM 8-K

CURRENT REPORT

 Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 2, 2002

VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)

DELAWARE                    0-26483                 94-3236309
(State or other jurisdiction    (Commission File       (I.R.S. Employer of      
   Identification Number)            Number)      incorporation or organization)

 1000 MARINA BLVD., SUITE 200 BRISBANE, CALIFORNIA 94005
 (Address of Principal Administrative Offices)

 Registrants Telephone Number, Including Area Code: (650) 624-1000

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
Item 5. Other Events.                                                           

On July 2, 2002, VaxGen, Inc. (the "Company") announced that its May 1, 1996    
License and Supply Agreement with Genentech, Inc. has been revised to give the  
Company greater flexibility in commercializing the Company's AIDS vaccine       
candidate.                                                                      

The press release is filed herewith as Exhibit 99.1 and incorporated herein by  
reference.                                                                      

The Amended and Restated License and Supply Agreement between VaxGen, Inc., and 
Genentech, Inc., entered into as of May 1, 2002 is filed herewith as Exhibit    
99.2 and incorporated herein by reference.                                      

On July 8, 2002, the Company announced that Piers Whitehead has joined the      
Company as Vice President of Corporate and Business Development.                

The press release is filed herewith as Exhibit 99.3 and incorporated herein by  
reference.                                                                      

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.     

(c) Exhibits.                                                                   

EXHIBIT       DESCRIPTION                                           

99.1          Press Release issued July 2, 2002.                    

   99.2          Amended and Restated License and Supply Agreement between
                    VaxGen, Inc., and Genentech, Inc., entered into as of May 1,
2002.                                   

99.3          Press Release issued July 8, 2002.                    

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the        
registrant has duly caused this report to be signed on its behalf by the        
undersigned hereunto duly authorized.                                           

                              VaxGen, Inc.
                              (Registrant)

Dated: July 15, 2002                             By: /s/ Carter A. Lee          
                                             ---------------------------
                               Carter A. Lee
                                       Senior Vice President
                                          Finance & Administration

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
 EXHIBIT INDEX

EXHIBIT No.         DESCRIPTION                                                 
-----------         -----------                                                 

99.1            Press Release issued July 2, 2002.                      

 99.2            Amended and Restated License and Supply Agreement between
                    VaxGen, Inc., and Genentech, Inc., entered into as of May 1,
2002.                                   

99.3            Press Release issued July 8, 2002.                      

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		7/15/02		3					None on these Dates
		7/8/02		2		4
For Period End:		7/2/02		1		4
		5/1/02		2		4
		5/1/96		2
									List all Filings